Dr. Michael C. Rommen, DO

Dr. Rommen practices at St. Francis Medical Center in Monroe, Louisiana, part of Franciscan Missionaries of Our Lady.

Dr. Rommen's NPI, 1164865036, was assigned on April 10, 2013. Dr. Rommen holds Oklahoma license 5619.

Dr. Rommen's primary practice is St. Francis Medical Center, at 309 Jackson Street, Monroe, LA 71201 in Ouachita Parish. The practice phone is (318) 966-4000.

Dr. Rommen's primary practice is St. Francis Medical Center in Monroe, Louisiana, part of Franciscan Missionaries of Our Lady. Dr. Rommen is also affiliated with Franklin Medical Center. The medical group on file is SCP Health. Dmand AI also links Dr. Rommen to 6 more medical groups, 1 group practice or clinic and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rommen practices, 4 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Rommen's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Rommen's licenses on file in 2 states: Oklahoma and Louisiana.

CMS data shows 1,028 Medicare services from Dr. Rommen across 5 procedure codes in 2024, for 608 Medicare patients. Medicare paid $80,207 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 608 Medicare patients who saw Dr. Rommen in 2024. The largest group is 75 to 84, with 210 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rommen's median patient age at 62, with 54% women.

In 2024, Dr. Rommen wrote 344 Medicare Part D claims for 224 patients. 91% of them were for generic drugs. CMS names the drug for 165 of them, across 9 drugs with 11 or more claims each, at $1,368 in total drug cost. In 2023, CMS named 184 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Rommen for performance year 2024, reported as part of a group. Dr. Rommen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Rommen.

CMS Open Payments shows 2 general payments to Dr. Rommen from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $16.